Libido PeptideHover to zoomQualified Research Reference
PT-141
PT-141 is documented for controlled research models and literature-based evaluation only.
- Regular
- $84.99
- Elite Member−10%
- $76.49
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist supplied as a lyophilized research peptide. Manufactured to a research-grade specification.
Studied in MC3R/MC4R signaling, central nervous system arousal pathways, and melanocortin pharmacology research.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
PT-141: investigational profile.
Research Mechanism
A synthetic melanocortin agonist investigated for MC3R and MC4R engagement and central-nervous-system arousal-pathway signaling. Related melanocortin work with Melanotan-2 is often referenced in the same literature.
Investigational Profile
Published characterization has accumulated since the early 2000s across melanocortin-pharmacology and central-signaling research.
Research Study Window
Central-signaling endpoints are typically captured across short one- to four-week laboratory observation windows.
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C50H68N14O10
- Molar Mass
- 1025.18 g/mol
- Amino Acid Sequence
- H-Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH
- Synonyms
- Bremelanotide, PT-141
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
